Skip to main content
. 2020 Dec 18;10(12):e038867. doi: 10.1136/bmjopen-2020-038867

Figure 2.

Figure 2

Tornado plot of the univariate sensitivity analyses for pembrolizumab versus standard-of-care therapy. ICER, incremental cost-effectiveness ratio; PEM, pembrolizumab; QALY, quality-adjusted life year; WTP, willingness-to-pay threshold.